Business News›Prime›Pharma›Prostate cancer: what the blue ribbon needs to unlearn from the pink ribbon
Disease
Prostate cancer: what the blue ribbon needs to unlearn from the pink ribbon
![Prostate cancer: what the blue ribbon needs to unlearn from the pink ribbon](https://img.etimg.com/thumb/msid-109862746,width-1015,height-761,imgsize-10644,resizemode-8/prime/pharma-and-healthcare/prostate-cancer-what-the-blue-ribbon-needs-to-unlearn-from-its-pink-counterpart.jpg)
![Prostate cancer: what the blue ribbon needs to unlearn from the pink ribbon](https://img.etimg.com/thumb/msid-109862746,width-1015,height-761,imgsize-10644,resizemode-8/prime/pharma-and-healthcare/prostate-cancer-what-the-blue-ribbon-needs-to-unlearn-from-its-pink-counterpart.jpg)
Synopsis
As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.
Dr Vedang Murthy, professor of radiation oncology and convenor of uro-oncology at Mumbai’s Tata Memorial Centre, encounters a steady stream of patients every year, each sharing a common narrative of symptoms. Most are men in the age group of 60-65 years who present a spectrum of urinary troubles including increased frequency, feeble stream, difficulty in retention, and occasionally, the disconcerting sight of blood in urine. After preliminary
- FONT SIZEAbcSmallAbcMediumAbcLarge
ET
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.